ERBB2 and breast cancer: In this study, we utilized HER2-overexpressing breast cancer cells, MCF7/HER2-5, as a model to evaluate the activities of synthetic curcumin analogues, PGV-0 and PGV-1, in HER2 and NFκB signaling pathways.